Insomnia in older adults: A review of treatment options.

Roberto León-Barriera, Margaret M Chaplin, Jasleen Kaur, Vania Modesto-Lowe

Review Cleveland Clinic journal of medicine 2025 12 citations

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'pmid\u003D39746731'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

Study Type: review

Intervention: Insomnia in older adults: A review of treatment options. various
Comparator: Placebo
Effect Direction: Positive
Risk of Bias: Moderate

Abstract

Insomnia is a common and challenging complaint in older adults (> 65 years) because of age-related alterations in sleep physiology. Cognitive behavioral therapy for insomnia is the gold standard for treatment of insomnia in young as well as older patients. Both clinicians and patients often prefer the simplicity of medication, but risks associated with some hypnotics increase with age. Pharmacologic options for older adults include low-dose doxepin, melatonin, ramelteon, and the dual orexin receptor antagonists. A well-informed clinician can help patients navigate the risks and benefits of both pharmacologic and behavioral options.

Used In Evidence Reviews

C Melatonin for Sleep-Related Cognitive Impairment

Insomnia in older adults: A review of treatment options.

Embed This Widget

Study Design

Abstract

Used In Evidence Reviews

Similar Papers

European guideline for the diagnosis and treatment of insomnia.

Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology.

A review of sleep disorders and melatonin.

Review of Safety and Efficacy of Sleep Medicines in Older Adults.

Dietary Sources and Bioactivities of Melatonin.

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.